Mackenzie Financial’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.99M Buy
46,100
+3,675
+9% +$753K 0.01% 566
2025
Q4
$11M Buy
42,425
+19,191
+83% +$5.03M 0.01% 486
2025
Q3
$6.04M Sell
23,234
-6,795
-23% -$1.79M 0.01% 601
2025
Q2
$7.34M Buy
30,029
+6,510
+28% +$1.62M 0.01% 533
2025
Q1
$6.22M Buy
23,519
+524
+2% +$142K 0.01% 534
2024
Q4
$5.83M Sell
22,995
-13,743
-37% -$3.69M 0.01% 550
2024
Q3
$11.6M Sell
36,738
-725
-2% -$258K 0.02% 417
2024
Q2
$14M Sell
37,463
-73,348
-66% -$24.8M 0.02% 386
2024
Q1
$38.4M Sell
110,811
-10,935
-9% -$4.14M 0.06% 248
2023
Q4
$55.7M Buy
121,746
+52,469
+76% +$25.9M 0.08% 199
2023
Q3
$33.8M Buy
69,277
+30,964
+81% +$14.6M 0.06% 246
2023
Q2
$17.1M Sell
38,313
-4,098
-10% -$2.06M 0.03% 362
2023
Q1
$20.6M Buy
42,411
+6,329
+18% +$3.13M 0.03% 329
2022
Q4
$18.5M Buy
36,082
+19,558
+118% +$10.3M 0.03% 321
2022
Q3
$8.02M Sell
16,524
-389
-2% -$189K 0.01% 449
2022
Q2
$7.92M Sell
16,913
-2,078
-11% -$925K 0.01% 466
2022
Q1
$8.26M Buy
18,991
+487
+3% +$204K 0.01% 494
2021
Q4
$8.58M Sell
18,504
-320
-2% -$142K 0.01% 508
2021
Q3
$7.33M Sell
18,824
-998
-5% -$424K 0.01% 504
2021
Q2
$8.78M Buy
19,822
+798
+4% +$349K 0.01% 473
2021
Q1
$7.98M Sell
19,024
-1,484
-7% -$592K 0.01% 455
2020
Q4
$8.41M Sell
20,508
-1,386
-6% -$576K 0.02% 370
2020
Q3
$9.06M Sell
21,894
-21,253
-49% -$8.55M 0.02% 316
2020
Q2
$16.7M Buy
43,147
+21,254
+97% +$7.95M 0.04% 244
2020
Q1
$6.88M Sell
21,893
-1,574
-7% -$531K 0.02% 311
2019
Q4
$8.6M Buy
23,467
+9,037
+63% +$2.87M 0.02% 350
2019
Q3
$3.69M Buy
14,430
+2,495
+21% +$700K 0.01% 505
2019
Q2
$3.17M Sell
11,935
-40,737
-77% -$10.3M 0.01% 539
2019
Q1
$14M Buy
52,672
+33,772
+179% +$9.73M 0.03% 324
2018
Q4
$5.41M Buy
18,900
+1,477
+8% +$468K 0.01% 487
2018
Q3
$5.9M Buy
17,423
+3,098
+22% +$1.01M 0.01% 462
2018
Q2
$4.26M Buy
14,325
+5,148
+56% +$1.51M 0.01% 485
2018
Q1
$2.47M Buy
9,177
+3,372
+58% +$913K 0.01% 536
2017
Q4
$1.44M Sell
5,805
-837
-13% -$207K ﹤0.01% 569
2017
Q3
$1.62M Buy
6,642
+232
+4% +$56.8K 0.01% 404
2017
Q2
$1.54M Buy
6,410
+346
+6% +$78.3K 0.01% 408
2017
Q1
$1.25M Buy
6,064
+2,251
+59% +$465K 0.01% 440
2016
Q4
$778K Buy
3,813
+244
+7% +$46.5K ﹤0.01% 466
2016
Q3
$631K Sell
3,569
-442
-11% -$76.7K ﹤0.01% 474
2016
Q2
$721K Sell
4,011
-564
-12% -$100K ﹤0.01% 686
2016
Q1
$837K Buy
4,575
+980
+27% +$170K 0.01% 557
2015
Q4
$642K Sell
3,595
-350
-9% -$61.4K ﹤0.01% 615
2015
Q3
$706K Sell
3,945
-46,030
-92% -$8.51M ﹤0.01% 601
2015
Q2
$9.56M Sell
49,975
-38,280
-43% -$7.1M 0.05% 256
2015
Q1
$15.7M Sell
88,255
-1,030
-1% -$163K 0.08% 213
2014
Q4
$12.8M Buy
89,285
+575
+0.6% +$78.6K 0.07% 223
2014
Q3
$11.6M Buy
88,710
+76,075
+602% +$9.67M 0.06% 242
2014
Q2
$1.61M Buy
12,635
+1,100
+10% +$130K 0.01% 444
2014
Q1
$1.3M Buy
11,535
+1,895
+20% +$197K 0.01% 449
2013
Q4
$995K Buy
9,640
+720
+8% +$70.5K 0.01% 493
2013
Q3
$833K Sell
8,920
-2,991
-25% -$274K ﹤0.01% 515
2013
Q2
$1M Buy
+11,911
New +$940K ﹤0.01% 495

Other funds holding HUM

Mackenzie Financial's HUM Position: Q1 2026 in Review

Mackenzie Financial increased its Humana (HUM) stake by 8.7% in Q1 2026, buying an estimated $753K and bringing the position to 46,100 shares worth $7.99M. The position accounts for 0.01% of the portfolio, ranked #566.

Mackenzie Financial first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.7M in Q4 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Mackenzie Financial held 46,100 shares of Humana worth $7.99M as of Q1 2026.
  • Mackenzie Financial bought 3,675 Humana shares in Q1 2026, an estimated $753K.
  • Humana made up 0.01% of Mackenzie Financial's portfolio in Q1 2026, its #566 holding.
  • Mackenzie Financial first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • Mackenzie Financial's Humana position peaked at $55.7M in Q4 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.